Literature DB >> 25783053

Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway.

Shuai Zheng1, Ying Yang2, Ran Song3, Xiaomei Yang3, Hua Liu3, Qian Ma1, Longyan Yang1, Ran Meng1, Tao Tao1, Songlin Wang4, Junqi He5.   

Abstract

Ang-(1-7) is an active peptide component of renin-angiotensin system and endogenous ligand for Mas receptor. In the current study, we showed that Ang-(1-7) enhanced migratory and invasive abilities of renal cell carcinoma cells 786-O and Caki-1 by wound-healing, transwell migration and transwell invasion assays. Mas antagonist A779 pretreatment or shRNA-mediated Mas knockdown abolished the stimulatory effect of Ang-(1-7). Furthermore, Ang-(1-7)-stimulated AKT activation was inhibited by either A779 pretreatment or Mas knockdown. Blockage of AKT signaling by AKT inhibitor VIII inhibited Ang-(1-7)-induced migration and invasion in 786-O cells. Taken together, our results provided the first evidence for the pro-metastatic role of Ang-(1-7) in RCC, which may help to better understand the molecular mechanism underlying the progression of this tumor.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT signaling; Angiotensin-(1-7); Invasion; Mas receptor; Migration; Renal cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 25783053     DOI: 10.1016/j.bbrc.2015.03.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

2.  MiR-34b-3p Impaired HUVECs Viability and Migration via Targeting PDK1 in an In Vitro Model of Gestational Diabetes Mellitus.

Authors:  Feiluan Song; Anli Cai; Qianwen Ye; Xiang Chen; Lin Lin; Xi Hao
Journal:  Biochem Genet       Date:  2021-04-15       Impact factor: 1.890

3.  Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.

Authors:  Peio Errarte; Maider Beitia; Itxaro Perez; Lorea Manterola; Charles H Lawrie; Jon Danel Solano-Iturri; Julio Calvete-Candenas; Miguel Unda; José I López; Gorka Larrinaga
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

Review 4.  The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer.

Authors:  Juanjuan Xu; Jinshuo Fan; Feng Wu; Qi Huang; Mengfei Guo; Zhilei Lv; Jieli Han; Limin Duan; Guorong Hu; Lian Chen; Tingting Liao; Wanli Ma; Xiaonan Tao; Yang Jin
Journal:  Front Physiol       Date:  2017-05-08       Impact factor: 4.566

5.  AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.

Authors:  Xinglu Chen; Sansan Chen; Nana Pei; Yingying Mao; Shengyao Wang; Renhe Yan; Na Bai; Andrew Li; Yanling Zhang; Hongyan Du; Baihong Chen; Colin Sumners; Jinlong Li; Hongwei Li
Journal:  Oncotarget       Date:  2017-01-03

6.  MicroRNA Profiling of the Effect of the Heptapeptide Angiotensin-(1-7) in A549 Lung Tumor Cells Reveals a Role for miRNA149-3p in Cellular Migration Processes.

Authors:  Brenda de Oliveira da Silva; Kelvin Furtado Lima; Letícia Rocha Gonçalves; Marina Bonfogo da Silveira; Karen C M Moraes
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

7.  Renin angiotensin system deregulation as renal cancer risk factor.

Authors:  Paweł Sobczuk; Cezary Szczylik; Camillo Porta; Anna M Czarnecka
Journal:  Oncol Lett       Date:  2017-08-25       Impact factor: 2.967

Review 8.  Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity.

Authors:  Dora L Vallejo-Ardila; Theodora Fifis; Louise M Burrell; Katrina Walsh; Christopher Christophi
Journal:  Oncotarget       Date:  2018-10-26

Review 9.  Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.

Authors:  Matthias Pinter; Rakesh K Jain
Journal:  Sci Transl Med       Date:  2017-10-04       Impact factor: 17.956

10.  Angiotensin 1-7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer.

Authors:  Kamila Domińska; Piotr Okła; Karolina Kowalska; Dominika Ewa Habrowska-Górczyńska; Kinga Anna Urbanek; Tomasz Ochędalski; Agnieszka Wanda Piastowska-Ciesielska
Journal:  Sci Rep       Date:  2018-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.